All the enrolled patients underwent plain and enhanced MRI of the pituitary gland with the 3.0-T MRI scanner (Siemens Healthcare, Erlangen, Germany) within 1 week before surgery. A 24-channel head/neck coil was used. The coronal, sagittal, and three-dimensional (3D) enhanced T1-weighted images (T1WIs) and T2-weighted images (T2WIs) were obtained. The imaging protocol included pre-contrast and contrast-enhanced coronal T1 sequences (repetition time (TR)/echo time (TE), 400/6.7 ms; slice thickness, 2 mm; 12 sections; field of view (FOV), 200 mm; flip angle, 150°; bandwidth, 399 Hz/pixel; pixel resolution, 256), contrast-enhanced sagittal T1 sequences (TR/TE, 440/3.5 ms; slice thickness, 2 mm; 12 sections; FOV, 240 mm; flip angle, 150°; bandwidth, 380 Hz/pixel; pixel resolution, 320), coronal T2 sequences (TR/TE, 3000/103 ms; slice thickness, 2 mm; 12 sections; FOV, 200 mm; flip angle, 150°; bandwidth, 260 Hz/pixel; pixel resolution, 320), and sagittal T2 sequences (TR/TE, 4000/110 ms; slice thickness, 2 mm; 12 sections; FOV, 260 mm; flip angle, 150°; bandwidth, 223 Hz/pixel; pixel resolution, 320). Gadopentetate dimeglumine or gadobenate dimeglumine was used as the contrast agent, and the dose was 0.2 mL/kg of body weight. T2WIs were obtained before the injection of the contrast agent.
Free full text: Click here